IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing cellular therapies for aging-related conditions.
Industry: Health Care
Latest Trade: $1.75 0.00 (0.0%)
First Day Return: -25.9%
Return from IPO: -98.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/19/2021 |
Offer Price | $10.00 |
Price Range $10.00 - $12.00 | |
Offer Shares (mm) | 2.7 |
Deal Size ($mm) | $27 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/11/2021 |
Offer Price | $10.00 |
Price Range $10.00 - $12.00 | |
Offer Shares (mm) | 2.7 |
Deal Size ($mm) | $27 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
EF Hutton |
Alexander Capital |
Company Data | |
---|---|
Headquarters | Miami, FL, United States |
Founded | 2014 |
Employees | 12 |
Website www.longeveron.com |